Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5594554 | American Heart Journal | 2016 | 29 Pages |
Abstract
In a real-world PCI registry, patients with DM experienced lower risk of bleeding risk on DAPT. As patients with DM also derive greater ischemic benefit from drug-eluting stents, which requires prolonged DAPT, our findings suggest that the balance between benefit and risk of this therapeutic approach may be even more favorable in patients with DM than previously considered.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Anna MD, Suzanne V. MD, MHA, Tracy Y. MD, MSc, Praneet MD, Kensey MS, Philip G. MS, Deepak L. MD, MPH, Philippe Gabriel MD, Darren K. MD, MHSc, David J. MD, MSc, John A. MD, MPH, Adnan K. MD, Marcus MD, PhD, Garth MD, MPH, Mikhail MD,